What are the indications and contraindications for the tablet containing cinnarizine 40 mg and diphenhydramine 20 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

INDICATION OF TAB CINNARIZINE 40 MG AND DIPHENHYDRAMINE 20 MG AND CONTRAINDICATION

Primary Indication

This specific combination of cinnarizine 40 mg and diphenhydramine 20 mg does not have established evidence-based indications, as the studied and validated formulation is cinnarizine 20 mg/dimenhydrinate 40 mg (not diphenhydramine). The doses and components in your question differ from the evidence-based fixed combination used in clinical practice.

Evidence-Based Alternative: Cinnarizine 20 mg/Dimenhydrinate 40 mg

The validated fixed-dose combination is cinnarizine 20 mg with dimenhydrinate 40 mg (not diphenhydramine), which has strong evidence for:

Approved Indications:

  • Peripheral vestibular vertigo - primary indication with superior efficacy 1
  • Central vestibular vertigo - effective for centrally-mediated symptoms 2
  • Mixed origin vertigo - addresses both peripheral and central dysfunction simultaneously 3

The cinnarizine/dimenhydrinate combination demonstrated superiority over betahistine 16 mg (the most widely prescribed antivertigo medication worldwide) with a mean vertigo score reduction of 0.395 vs 0.488 (p=0.035), achieving 78% responder rate versus lower rates with monotherapies 1. This combination works through dual mechanisms: cinnarizine acts peripherally on the vestibular system while dimenhydrinate acts centrally 3.

Contraindications

For Diphenhydramine Component 4:

  • Hypersensitivity to diphenhydramine or any inactive ingredients
  • Chronic bronchitis or other breathing problems - can worsen respiratory function
  • Glaucoma - anticholinergic effects increase intraocular pressure
  • Prostatic hypertrophy with urinary retention - anticholinergic effects worsen urinary obstruction
  • Concurrent use with other diphenhydramine-containing products - risk of overdose
  • Children under 6 years - not approved for this age group 4

For Cinnarizine Component 5:

  • Hypersensitivity to cinnarizine or related compounds (meclizine class)

Important Precautions 4:

  • Avoid alcohol and CNS depressants - marked additive drowsiness
  • Caution with sedatives/tranquilizers - increased sedation risk
  • Pregnancy and breastfeeding - requires healthcare professional consultation
  • Operating machinery/driving - significant drowsiness impairs function
  • Elderly patients - increased anticholinergic sensitivity

Critical Clinical Caveat

The combination you're asking about (cinnarizine 40 mg + diphenhydramine 20 mg) is NOT the evidence-based formulation. The studied and validated combination is cinnarizine 20 mg + dimenhydrinate 40 mg, which has demonstrated superior efficacy in multiple randomized controlled trials 2, 1, 3.

Diphenhydramine has actually been removed from antiemetic guidelines 6 because its original rationale (preventing metoclopramide-induced akathisia) is no longer relevant with modern antiemetic regimens. Using diphenhydramine instead of dimenhydrinate lacks clinical evidence and may provide suboptimal vertigo control.

If treating vestibular vertigo, use the validated cinnarizine 20 mg/dimenhydrinate 40 mg combination three times daily for 4 weeks 1, not the formulation mentioned in your question.

References

Related Questions

What are the uses and contraindications of the combination of cinnarizine 20 mg and dimenhydrinate 40 mg?
Are there any drug interactions between cinnarizine, dimenhydrinate, and pregabalin?
How should cinnarizine be dosed for motion sickness and peripheral vestibular vertigo, and what are the safety precautions and contraindications?
Can Cinnarizine 25 mg, Meclizine, and Betahistine (Vertin) 16 mg be given together?
Is it safe to combine betahistine, cinnarizine, and prochlorperazine in a patient with vertigo or Meniere's disease?
What severe, immediately life‑threatening conditions can be missed on physical examination or in an urgent‑care setting?
In an adult patient without contraindications, should Botox (onabotulinumtoxinA) and a hyaluronic‑acid dermal filler be administered in the same session, and which should be performed first?
In which clinical situations should tigecycline be administered at a double dose (100 mg IV every 12 hours after a 100 mg loading dose)?
What is the appropriate acute and long‑term management of hyponatremia and hyperkalemia in a patient with adrenal insufficiency?
What are the typical clinical presentations of pontine cavernoma?
What is the most likely diagnosis in a patient with ST‑segment elevation on ECG, positive troponin I, a normal echocardiogram, and markedly elevated serum creatinine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.